Article
Clinical significance of preleukemic somatic GATA1 mutations in children with Down syndrome
25 Jun 2025
Abstract excerpt
ABSTRACT: Children with Down syndrome (DS) have a high risk of GATA1-associated myeloid leukemia (ML-DS) before age 4 years. Somatic N-terminal GATA1 mutations (GATA1s) are necessary, but not sufficient, for ML-DS, but their significance at birth for individual babies and whether mutations occur after birth is unclear. To address these questions, we performed a prospective study of newborns with DS using...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
